The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 20, 2015
Filed:
Oct. 14, 2009
Applicants:
Danica Stanimirovic, Greely, CA;
Abedelnasser Abulrob, Orleans, CA;
Maria Moreno, Ottawa, CA;
Inventors:
Assignee:
National Research Council of Canada, Ottawa, CA;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/395 (2006.01); G01N 33/53 (2006.01); G01N 23/04 (2006.01); G01N 23/083 (2006.01); G01N 33/574 (2006.01); A61K 49/00 (2006.01); C07K 16/32 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57407 (2013.01); A61K 49/0032 (2013.01); A61K 49/0058 (2013.01); C07K 16/32 (2013.01); G01N 33/6854 (2013.01); A61K 2039/505 (2013.01); C07K 2317/22 (2013.01); C07K 2317/569 (2013.01); G01N 2333/4745 (2013.01);
Abstract
The invention relates to antibodies or fragments thereof specific for insulin-like growth factor binding protein-7 (IGFBP7). A method of raising anti-IGFBP7 single domain antibodies is also disclosed and specific antibody clones are described, along with their binding characteristics. The anti-IGFBP7 antibodies may be useful as diagnostic tools for detecting neoplastic diseases involving tumor angiogenesis, and a variety of other angiogenesis associated diseases.